For many years, genetically obese mouse strains have provided models for hu
man obesity. The A(vy)/-agouti mouse, one of the oldest obese mouse models,
is characterized by maturity-onset obesity and diabetes as a result of ect
opic expression of the secreted protein hormone, agouti protein. Agouti pro
tein is normally expressed in hair follicles to regulate pigmentation throu
gh antagonism of the melanocortin-1 receptor, but in-vitro studies have dem
onstrated that the hormone also has potent antagonist activity for the mela
nocortin-4 receptor (MC4-R). Subsequent development of the MC4-R knockout m
ouse model demonstrated that MC4-R plays a role in weight homeostasis as th
ese mice recapitulated the metabolic defects of the agouti mouse. Further e
vidence for this hypothesis was obtained from pharmacological studies utili
zing peptides with MC4-R agonist activity, that inhibitied food intake (whe
n administered intracerebrarly), Additional studies with peptide antagonist
s have now implicated the MC4-R in the leptin signalling pathway. Finally,
evidence that the MCC-R may play a role in human obesity has been obtained
from the identification of a dis-functional variant of the receptor in gene
tically obese subjects.